About this trial
Sickle cell disease is a chronic disease characterized by multiple vaso-occlusive complications. The basic treatment for patients with a vaso-occlusive crisis (VOC) is based on adequate hydration, oxygen therapy and pain control. Loco Regional Anesthesia (LRA) is one of the major treatments in resuscitation anesthesia for both anesthesia and analgesia. LRA allows effective and almost immediate pain control by blocking nerve afferents in a given area. LRA could decrease the inflammatory response during crises and accelerate resolution of the crisis.
Eligibility criteria
Qualifiers
patients adult >18 years
patients with vaso-occlusive crisis
Disqualifiers
Pregnant or breastfeeding women
Blood transfusion within the last 3 months
Lack of affiliation with the French social security system
Protected individuals
Trial design
Treatments tested in this trial
- Not listed